Literature DB >> 6192208

Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.

K Fuxe, L F Agnati, F Benfenati, M Celani, I Zini, M Zoli, V Mutt.   

Abstract

Substance P (SP) (10(-8) M) can rapidly reduce the affinity and increase the density of 3H-5-HT binding sites in spinal cord membranes. CCK-8 and CCK-4 (10(-8) M) can rapidly and differentially change the characteristics of 3H-spiperone striatal binding sites linked to DA receptors of the D2 type. CCK-4 increase and CCK-8 reduce the number of striatal binding sites for 3H-spiperone, indicating for the first time separate CCK-4 binding sites. CCK-4 (10(-8) M) but not CCK-8 (10(-8) M) can rapidly reduce the affinity and increase the number of the 3H-spiperone binding sites linked to 5-HT receptors of the dorsal cerebral cortex of rats. CCK-8 (10(-8) M) only produces a trend for a small increase in the Bmax values of these receptors. These results again imply the existence of separate CCK-4 binding sites in this case in the cerebral cortex. Glutamate (10(-6) M), but not N-methyl-D-aspartate (10(-6) M) can rapidly change the characteristics of the 3H-N-propylnorapomorphine (3H-NPA) binding sites in striatal membranes of rats. Glutamate (10(-6) M) increases the density and especially reduces the affinity of the 3H-NPA binding sites, which label D2 and D3 types of DA receptors. Taken together the present findings give evidence that neuropeptide receptors and glutamate receptors can in vitro rapidly modulate the characteristics of different types of DA and 5-HT receptors by way of receptor--receptor interactions at the comodulate level or at the local circuit level. It is hypothesized that these receptor--receptor interactions are of importance for the encoding of short-term memory.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192208

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  38 in total

Review 1.  On the molecular basis of the receptor mosaic hypothesis of the engram.

Authors:  Luigi F Agnati; Sergi Ferré; Giuseppina Leo; Carme Lluis; Enric I Canela; Rafael Franco; Kjell Fuxe
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

Review 2.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

Review 3.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

4.  G-protein-coupled receptor heteromer dynamics.

Authors:  Jean-Pierre Vilardaga; Luigi F Agnati; Kjell Fuxe; Francisco Ciruela
Journal:  J Cell Sci       Date:  2010-12-15       Impact factor: 5.285

Review 5.  How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics.

Authors:  Luigi F Agnati; Diego Guidolin; Susanna Genedani; Sergi Ferré; Albertino Bigiani; Amina S Woods; Kjell Fuxe
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  A summary and conclusions from the meeting.

Authors:  Fiona H Marshall
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 7.  Intramembrane receptor-receptor interactions: a novel principle in molecular medicine.

Authors:  K Fuxe; M Canals; M Torvinen; D Marcellino; A Terasmaa; S Genedani; G Leo; D Guidolin; Z Diaz-Cabiale; A Rivera; L Lundstrom; U Langel; J Narvaez; S Tanganelli; C Lluis; S Ferré; A Woods; R Franco; L F Agnati
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

Review 8.  Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Miklós Palkovits; Alexander O Tarakanov; Francisco Ciruela; Luigi F Agnati
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

9.  Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.

Authors:  M Strittmatter; G F Hamann; D Strubel; H Cramer; K Schimrigk
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

10.  Neuropeptide Y enhances the inhibitory effects of clonidine on 3H-noradrenaline release in synaptosomes isolated from the medulla oblongata of the male rat.

Authors:  M Martire; K Fuxe; G Pistritto; P Preziosi; L F Agnati
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.